Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Quick and long-lasting responsiveness by ephedrine in an adult woman with congenital myasthenic syndrome associated with a novel COLQ mutation.
Neuromuscular and Clinical Neurophysiology (EMG)
Neuromuscular and Clinical Neurophysiology (EMG) Posters (7:00 AM-5:00 PM)
147
To characterize an adult-onset case of endplate acetylcholinesterase (AChE) deficiency associated with a novel COLQ gene mutation, we examined the clinical complaints and electrophysiological features. Furthermore, we investigated the effect of ephedrine administration, which has been reported to be effective in congenital myasthenic syndrome (CMS) that occurs in early childhood.
CMS is defined as a defect and functional abnormality in neuromuscular junctions that causes fatigue and many other symptoms. Although some gene mutations are reported, no effective treatments have been established yet, especially in adult cases. 
A case study on a 26-year-old female.

From birth, she had generalized muscle weakness and delayed motor development, but later eventually acquired ambulation. However, after growing up, easy fatigability, mild muscle weakness in the proximal muscles of the extremities, dysphagia, and respiratory dysfunction reappeared upon infection and menstruation. Electrophysiological examination displayed waning in the repetitive stimulation test and repetitive compound muscle action potential in the nerve conduction velocity test. Genetic analysis revealed a novel heterozygous mutation in the COLQ gene (c.1216G>A p.G406R:c.600+2T>C), resulted in a definitive diagnosis of endplate AChE deficiency. When ephedrine (1.7 mg/kg/day) was administered, the patient promptly ceased to have easy fatigability and rescued from muscle weakness that appeared during menstruation and infection. She had settled in over the course of two years with no exacerbation of her symptoms.

We demonstrated that endplate AChE deficiency which causes muscle weakness exacerbated by infection and menstruation should be added as a new category in the differential diagnosis. We also demonstrated quick and long-lasting responsiveness by ephedrine even in an adult-onset case with CMS with this novel mutation.

Authors/Disclosures
Kazuhiro Higashida (Gifu university)
PRESENTER
Kazuhiro Higashida has nothing to disclose.
No disclosure on file
Takayoshi Shimohata, MD, FÂé¶¹´«Ã½Ó³»­ (Department of Neurology, Gifu University) Dr. Shimohata has nothing to disclose.